Notice Regarding of Implementation of Structural Reforms for Profit Improvement by our Subsidiary
(Takara Bio Inc.)
Takara Bio Inc. (The First Section of Tokyo Stock Exchange, securities code number: 4974), a consolidated subsidiary of the Company, today issued a news release entitled “Notice Regarding the implementation of structural reforms for profit improvement aimed at the revenue structure”. For details, please refer to the disclosure materials of Takara Bio.
The impact of this structural reform on the performance for the fiscal year ending March 2027 has been factored into the consolidated earnings forecast announced today.
(Attached) Disclosure materials of Takara Bio
